The new 2022 pulmonary hypertension guidelines: some small steps and some giant leaps forward for evidence-based care
- PMID: 36609524
- DOI: 10.1183/13993003.02150-2022
The new 2022 pulmonary hypertension guidelines: some small steps and some giant leaps forward for evidence-based care
Conflict of interest statement
Conflict of interest: L.C. Price reports grants from Ferrer and Altavant; honoraria for educational events from Janssen; travel support from Janssen and Ferrer; outside the submitted work. J. Weatherald reports grants from Janssen, Actelion and Bayer; consulting fees from Janssen and Actelion; lecture honoraria from Janssen; payment for expert testimony from Sprigings Intellectual Property Law; travel support from Janssen; advisory board membership with Janssen, Acceleron and Université Laval; and an unpaid role on the medical advisory committee for the Pulmonary Hypertension Association of Canada; outside the submitted work.
Comment on
-
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.Eur Respir J. 2023 Jan 6;61(1):2200879. doi: 10.1183/13993003.00879-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36028254 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical